New EMA policy on access to documents still falls short, say campaigners

BMJ 2017; 357 doi: (Published 18 May 2017) Cite this as: BMJ 2017;357:j2444
  1. Jacqui Wise
  1. London

Proposed changes to the way the European Medicines Agency allows access to documents it holds are still too restrictive, warn campaigners.

The EMA launched a public consultation on the revision to its policy on access to documents, which invited stakeholders to comment by 18 May 2017.1

A coalition of organisations—Health Action International, the International Society of Drug Bulletins, NoGracias, the Nordic Cochrane Centre, and the journal Prescrire—said that the revised policy falls short on proactive disclosure.2

In a joint response they raised the concern that …

View Full Text

Log in

Log in through your institution


* For online subscription